Evaluation of the inhibitory potentials of selected compounds from Costus spicatus (Jacq.) rhizome towards enzymes associated with insulin resistance in polycystic ovarian syndrome: an in silico study
Tóm tắt
Polycystic ovary syndrome (PCOS) is a chronic endocrine disorder prevalent in premenopausal women and is characterized by a range of physiological and biochemical abnormalities which may include reproductive, endocrine, and metabolic alterations such as insulin resistance. Insulin resistance is the hallmark of PCOS as it predisposes the affected subjects to a higher risk of impaired glucose tolerance and type 2 diabetes mellitus (T2DM). In this study, the inhibitory activities of phytosterols and saccharides from aqueous extract of Costus spicatus rhizome were investigated against phosphoenolpyruvate carboxykinase (PEPCK), α-amylase, β-glucosidase, and fructose 1,6-biphosphatase (FBPase) in silico as potential novel therapeutic targets for T2DM-associated-PCOS. Phytochemical constituents of the plant were determined using gas chromatography-mass spectrophotometry (GC-MS), while molecular docking of the compounds with PEPCK, α-amylase, β-glucosidase, and FBPase was conducted using Vina. Thereafter, the binding modes were determined using Discovery Studio Visualizer, 2020. GCMS analysis of an aqueous extract of Costus spicatus rhizome revealed the presence of three compounds with a higher binding affinity for all enzymes studied compared to metformin. The compounds also interacted with key amino acid residues crucial to the enzyme’s activities. This study identified Lyxo-d-manno-nononic-1,4-lactone as potential multi-target inhibitors of PEPCK, α-amylase, β-glucosidase, and FBPase with reasonable pharmacokinetic properties and no significant toxicity. These compounds can be explored as potential therapeutic agents for the management of insulin resistance in PCOS, subject to further experimental validation.
Tài liệu tham khảo
Makhouri FR, Ghasemi JB (2018) In silico studies in drug research against neurodegenerative diseases. Curr Neuropharmacol 16:664–725. https://doi.org/10.2174/1570159X15666170823095628
Gupta R, Srivastava D, Sahu M et al (2021) Artificial intelligence to deep learning: machine intelligence approach for drug discovery. Mol Divers:1–46. https://doi.org/10.1007/s11030-021-10217-3
Ekins S, Mestres J, Testa B (2007) In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling. Br J Pharmacol 152:9–20
Batool M, Ahmad B, Choi S (2019) A structure-based drug discovery paradigm. Int J Mol Sci 20:2783. https://doi.org/10.3390/ijms20112783
Sliwoski G, Kothiwale S, Meiler J, Lowe EW (2014) Computational methods in drug discovery. Pharmacol Rev 66:334–395
Witchel SF, Oberfield SE, Peña AS (2019) Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls. J Endocr Soc 3:1545–1573
Rosenfield RL, Ehrmann DA (2016) The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev 37:467–520
Jonard S, Dewailly D (2004) The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum Reprod Update 10:107–117
Luo Y, Cui C, Han X et al (2021) The role of miRNAs in polycystic ovary syndrome with insulin resistance. J Assist Reprod Genet 6;1–16
Sim L, Jayakanthan K, Mohan S et al (2010) New glucosidase inhibitors from an ayurvedic herbal treatment for type 2 diabetes: structures and inhibition of human intestinal maltase-glucoamylase with compounds from Salacia reticulata. Biochemistry 49:443–451
Westermeier F, Holyoak T, Gatica R et al (2020) Cytosolic phosphoenolpyruvate carboxykinase is expressed in α-cells from human and murine pancreas. J Cell Physiol 235:166–175
Oyedemi SO, Oyedemi BO, Ijeh II et al (2017) Alpha-amylase inhibition and antioxidative capacity of some antidiabetic plants used by the traditional healers in Southeastern Nigeria. Sci World J 2017. https://doi.org/10.1155/2017/3592491
Gondokesumo ME, Kusuma HSW, Widowati W (2017) α-/β-glucosidase and α-amylase inhibitory activities of roselle (Hibiscus sabdariffa L.) ethanol extract. Mol Cell Biomed Sci 1:34–40
de Melo EB, da Silveira GA, Carvalho I (2006) α-and β-Glucosidase inhibitors: chemical structure and biological activity. Tetrahedron 62:10277–10302
Kaur R, Dahiya L, Kumar M (2017) Fructose-1, 6-bisphosphatase inhibitors: a new valid approach for management of type 2 diabetes mellitus. Eur J Med Chem 141:473–505. https://doi.org/10.1016/j.ejmech.2017.09.029
Azhagu Madhavan S, Ganesan S (2021) Phytochemicals analysis of anti-diabetic effect of costus spicatus in Streptozotocin-induced diabetic albino wistar male rats. Eur J Res Dev Sustain 2
Hegde PK, Rao HA, Rao PN (2014) A review on insulin plant (Costus igneus Nak). Pharmacogn Rev 8:67
O’Boyle NM, Banck M, James CA et al (2011) Open babel: an open chemical toolbox. J Cheminform 3:33. https://doi.org/10.1186/1758-2946-3-33
Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455–461. https://doi.org/10.1002/jcc.21334
Pires DEV, Blundell TL, Ascher DB (2015) pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem. https://doi.org/10.1021/acs.jmedchem.5b00104
Walters KA, Paris VR, Aflatounian A, Handelsman DJ (2019) Androgens and ovarian function: translation from basic discovery research to clinical impact. J Endocrinol 242:R23–R50. https://doi.org/10.1530/JOE-19-0096
Duică F, Dănilă CA, Boboc AE et al (2021) Impact of increased oxidative stress on cardiovascular diseases in women with polycystic ovary syndrome. Front Endocrinol (Lausanne) 12
Ganai SA, Farooq Z, Banday S, Altaf M (2018) In silico approaches for investigating the binding propensity of apigenin and luteolin against class i HDAC isoforms. Future Med Chem. https://doi.org/10.4155/fmc-2018-0020
Dumitrescu R, Mehedintu C, Briceag I et al (2015) Metformin-clinical pharmacology in PCOs. J Med Life 8:187
Ferreira A, Pousinho S, Fortuna A et al (2015) Flavonoid compounds as reversal agents of the P-glycoprotein-mediated multidrug resistance: biology, chemistry and pharmacology. Phytochem Rev 14:233–272. https://doi.org/10.1007/s11101-014-9358-0
Yates JWT, Arundel PA (2008) On the volume of distribution at steady state and its relationship with two-compartmental models. J Pharm Sci 97:111–122. https://doi.org/10.1002/jps.21089
Crake RLI, Strother MR, Phillips E et al (2021) Influence of serum inflammatory cytokines on cytochrome P450 drug metabolising activity during breast cancer chemotherapy: a patient feasibility study. Sci Rep 11:1–11. https://doi.org/10.1038/s41598-021-85048-1
Fatunde OA, Brown S-A (2020) The role of CYP450 drug metabolism in precision cardio-oncology. Int J Mol Sci 21:604. https://doi.org/10.3390/ijms21020604
Lynch T, Price A (2007) The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Am Fam Physician 76:391–396